NMPA Approval

Polatuzumab Vedotin for Injection

Approval Number

国药准字SJ20230004

Registration Date

January 10, 2023

Drug Information

Generic Name

注射用维泊妥珠单抗

Trade Name

优罗华

Dosage Form

注射剂

Strength

30mg/瓶

Drug Type

生物制品

Registration Date

January 10, 2023

Expiry Date

January 9, 2028

Company Address

Grenzacherstrasse 124, 4058 Basel, Switzerland

Company Address

Wurmisweg, Kaiseraugst, 4303, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

注射用维泊妥珠单抗 - NMPA 批准文号 | MedPath